African Gold Limited (A1G) ORDINARY FULLY PAID |
Materials |
$111 |
African Gold Investor Presentation - July 2025
|
10 Jul 2025 9:40AM |
$0.185 |
$0.210 |
risen by
13.51%
|
|
Whitefield Income Limited (WHI) ORDINARY FULLY PAID |
Financials |
$224 |
Dividend/Distribution - WHI
|
10 Jul 2025 9:40AM |
$1.420 |
$1.395 |
fallen by
1.76%
|
|
Elevate Uranium Ltd (EL8) ORDINARY FULLY PAID |
Energy |
$96 |
NT Exploration Grant Awarded for drilling at Angela
|
10 Jul 2025 9:37AM |
$0.260 |
$0.250 |
fallen by
3.85%
|
|
Whitefield Income Limited (WHI) ORDINARY FULLY PAID |
Financials |
$224 |
Whitefield Income Monthly Dividends Jul, Aug, Sep
|
10 Jul 2025 9:36AM |
$1.420 |
$1.395 |
fallen by
1.76%
|
|
WHI - Price-sensitive ASX Announcement
Full Release
Key Points
- Whitefield Income Limited (WHI) announced monthly dividends for July, August, and September.
- Dividend amounts and payment schedules are detailed for each respective month.
- The board resolved to continue regular monthly income distributions to shareholders.
- Record dates and payment dates are specified for each dividend.
- WHI's announcement demonstrates its ongoing commitment to providing monthly income.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
GTI Energy Ltd (GTR) ORDINARY FULLY PAID |
Materials |
$12 |
Application for quotation of securities - GTR
|
10 Jul 2025 9:35AM |
$0.004 |
$0.004 |
risen by
14.29%
|
|
Trigg Minerals Limited (TMG) ORDINARY FULLY PAID |
Materials |
$71 |
Trading Halt
|
10 Jul 2025 9:35AM |
$0.076 |
$0.076 |
fallen by
0%
|
|
TMG - Price-sensitive ASX Announcement
Full Release
Key Points
- Trigg Minerals Limited (TMG) requested a trading halt on 3 June 2024.
- The trading halt was requested in anticipation of a capital raising announcement.
- The halt is to ensure an orderly market and to prevent trading on an uninformed basis.
- The trading halt will remain until either the capital raising announcement is made or trading resumes on 5 June 2024.
- The company has contacted ASX to request the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$65 |
Articore Board recommends vote against EGM Resolutions
|
10 Jul 2025 9:33AM |
$0.220 |
$0.230 |
risen by
4.55%
|
|
ATG - Price-sensitive ASX Announcement
Full Release
Key Points
- The Articore Board recommends shareholders vote AGAINST all EGM resolutions.
- The EGM was requisitioned by certain shareholders seeking to replace current directors.
- The Board argues the proposed new directors lack relevant experience and qualifications.
- The Board expresses concern that director changes would disrupt business operations.
- Articore’s current strategy is in execution and could be undermined by Board changes.
- The Board emphasizes the importance of stability and continuity for the company.
- Shareholders are encouraged to support the current Board and management team.
- The Board provides its rationale for opposition in detail, addressing shareholder concerns.
- Voting instructions and information about the EGM are included in the document.
- The announcement is dated 12 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$4 |
Imagion Receive Positive FDA Feedback for HER2 Phase 2 Trial
|
10 Jul 2025 9:33AM |
$0.013 |
$0.019 |
risen by
52%
|
|
IBX - Price-sensitive ASX Announcement
Full Release
Key Points
- Imagion Biosystems received positive FDA feedback for its planned Phase 2 trial of the MagSense HER2 imaging agent.
- The FDA agreed with the proposed study design, endpoints, and patient population.
- The feedback supports IBX’s regulatory and clinical development strategy.
- The Phase 2 trial will assess safety and effectiveness in detecting HER2-positive breast cancer.
- The company is moving forward with clinical site engagement and trial preparations.
- This milestone advances IBX’s goal of commercializing its MagSense technology for breast cancer diagnosis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
TMK Energy Limited (TMK) ORDINARY FULLY PAID |
Energy |
$31 |
Board Succession Update
|
10 Jul 2025 9:32AM |
$0.003 |
$0.003 |
risen by
20%
|
|
Moab Minerals Limited (MOM) ORDINARY FULLY PAID |
Materials |
$3 |
Proposed issue of securities - MOM
|
10 Jul 2025 9:31AM |
$0.001 |
$0.002 |
risen by
50%
|
|
Moab Minerals Limited (MOM) ORDINARY FULLY PAID |
Materials |
$3 |
Placement and Loan
|
10 Jul 2025 9:31AM |
$0.001 |
$0.002 |
risen by
50%
|
|
Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$4 |
Proposed issue of securities - LSR
|
10 Jul 2025 9:30AM |
$0.010 |
$0.010 |
fallen by
0%
|
|
AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$207 |
Proposed issue of securities - AUC
|
10 Jul 2025 9:29AM |
$0.615 |
$0.580 |
fallen by
5.69%
|
|
AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$207 |
Ausgold raises $35M to accelerate development of the KGP
|
10 Jul 2025 9:29AM |
$0.615 |
$0.580 |
fallen by
5.69%
|
|
AUC - Price-sensitive ASX Announcement
Full Release
Key Points
- Ausgold Limited has raised $35 million to accelerate the Katanning Gold Project (KGP).
- The raising consists of a placement to institutional and sophisticated investors and a share purchase plan.
- Funds will be used for feasibility studies, permitting, approvals, resource growth, and early project infrastructure.
- KGP is located in Western Australia and hosts a large gold resource with significant exploration upside.
- The capital raising positions Ausgold to transition KGP towards development and potential gold production.
- Leadership emphasizes the strategic timing given strong gold prices and growing interest from investors.
- The company aims to de-risk the project and deliver shareholder value with the new funding.
- The announcement was released to the ASX on 12 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Diablo Resources Limited (DBO) ORDINARY FULLY PAID |
Materials |
$2 |
Trading Halt
|
10 Jul 2025 9:29AM |
$0.015 |
$0.015 |
fallen by
0%
|
|
DBO - Price-sensitive ASX Announcement
Full Release
Key Points
- Diablo Resources Limited requested a trading halt on 5 December 2023.
- The trading halt was requested pending an announcement regarding a capital raising.
- The halt was expected to end upon the announcement or at the commencement of trading on 7 December 2023.
- Request made under ASX Listing Rule 17.1.
- No additional material information provided in the first 60 pages.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Vulcan Energy Resources Limited (VUL) ORDINARY FULLY PAID |
Materials |
$875 |
FSE Announcement
|
10 Jul 2025 9:28AM |
$4.000 |
$4.000 |
fallen by
0%
|
|
Chariot Corporation Ltd (CC9) ORDINARY FULLY PAID |
Materials |
$8 |
Reinstatement to Quotation
|
10 Jul 2025 9:25AM |
$0.055 |
$0.070 |
risen by
27.27%
|
|
CC9 - Price-sensitive ASX Announcement
Full Release
Key Points
- Chariot Corporation Ltd (ASX: CC9) is reinstated to official quotation on ASX as of 19 June 2024.
- Reinstatement follows compliance with listing rule 11.1.3 and satisfaction of ASX conditions.
- Company completed the acquisition of the Salinas Lithium Project.
- Capital raising was successfully completed as part of the reinstatement process.
- Details of capital structure and escrowed securities provided.
- Relevant disclosures and updated information about company activities released.
- Conditions precedent to reinstatement, including public announcement, satisfied.
- Trading information and arrangements for reinstated securities outlined.
- Restricted securities and vesting details disclosed.
- Company's updated focus is on lithium exploration and development following the acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Chariot Corporation Ltd (CC9) ORDINARY FULLY PAID |
Materials |
$8 |
Proposed issue of securities - CC9
|
10 Jul 2025 9:25AM |
$0.055 |
$0.070 |
risen by
27.27%
|
|
Chariot Corporation Ltd (CC9) ORDINARY FULLY PAID |
Materials |
$8 |
Proposed issue of securities - CC9
|
10 Jul 2025 9:25AM |
$0.055 |
$0.070 |
risen by
27.27%
|
|
Montaka Global Long Only Equites Fund (Managed Fund) (MOGL) |
Financials |
$128 |
MOGL -Distribution - 30 June 2025
|
10 Jul 2025 9:25AM |
$4.740 |
$4.770 |
risen by
0.63%
|
|
Chariot Corporation Ltd (CC9) ORDINARY FULLY PAID |
Materials |
$8 |
Chariot enters into Working Capital Facility Agreement
|
10 Jul 2025 9:25AM |
$0.055 |
$0.070 |
risen by
27.27%
|
|
Chariot Corporation Ltd (CC9) ORDINARY FULLY PAID |
Materials |
$8 |
Chariot to Acquire 67% Stake in Nigerian Lithium Portfolio
|
10 Jul 2025 9:25AM |
$0.055 |
$0.070 |
risen by
27.27%
|
|
CC9 - Price-sensitive ASX Announcement
Full Release
Key Points
- Chariot Corporation Ltd is acquiring a 67% stake in CC9’s Nigerian lithium portfolio.
- The portfolio consists of eight tenements covering approximately 1,700 km² in Nigeria.
- CC9 will retain a 33% minority interest after the acquisition.
- The deal involves a combination of upfront and milestone-based payments, both in cash and Chariot shares.
- The lithium tenements are considered highly prospective for large-scale lithium pegmatites.
- The acquisition is designed to strengthen Chariot’s position in the West African lithium sector.
- This move is part of Chariot’s strategy to build a diversified, high-quality lithium portfolio.
- The portfolio provides exposure to the growing demand for lithium, driven by electric vehicles and energy storage markets.
- The transaction is expected to enhance shareholder value through exploration and potential future lithium production.
- Due diligence and regulatory processes are expected to be completed to finalize the acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$5,576 |
Investor Conference Call Details Q2 2025 Results
|
10 Jul 2025 9:23AM |
$33.010 |
$32.800 |
fallen by
0.64%
|
|
Turaco Gold Limited (TCG) ORDINARY FULLY PAID |
Materials |
$504 |
High Grade Gold in Drilling Surrounding Woulo Woulo
|
10 Jul 2025 9:22AM |
$0.465 |
$0.485 |
risen by
4.30%
|
|
TCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Turaco Gold Limited announced high-grade gold discoveries at the Woulo Woulo prospect in Côte d’Ivoire.
- Key drilling intercepts include 17m at 5.96g/t gold and 15m at 3.43g/t gold in RC drilling.
- High-grade gold zones have been identified in fresh rock, not just oxide material.
- The mineralized footprint across Woulo Woulo continues to grow with ongoing drilling.
- Drilling has expanded the project's gold potential and resource development opportunities.
- Further drilling is planned to test parallel mineralized trends and step-out from current discoveries.
- Management emphasized the significance of these results for Turaco’s broader exploration strategy in the region.
- The company’s exploration program is fully funded, with more RC and diamond drilling planned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Macquarie Subordinated Debt Active ETF (MQSD) |
Financials |
$95 |
Product Disclosure Statement Update
|
10 Jul 2025 9:21AM |
$49.860 |
$49.870 |
risen by
0.02%
|
|